Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download


  Free Subscription


1 Acad Emerg Med
2 AJR Am J Roentgenol
2 Am J Obstet Gynecol
10 Am J Respir Crit Care Med
12 Ann Intern Med
1 Antiviral Res
45 BMJ
1 Clin Chem
22 Clin Infect Dis
10 Emerg Infect Dis
3 Eur J Radiol
6 Infect Control Hosp Epidemiol
14 Int J Infect Dis
5 Intensive Care Med
1 J Infect
25 J Med Virol
1 J Thorac Oncol
4 J Travel Med
1 J Virol
11 Lancet
1 Lancet Child Adolesc Health
4 Lancet Glob Health
6 Lancet Infect Dis
5 Lancet Psychiatry
5 Lancet Respir Med
2 Life Sci
12 MMWR Morb Mortal Wkly Rep
19 N Engl J Med
14 Nature
1 Radiology
16 Science
1 Travel Med Infect Dis

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acad Emerg Med

    Inequities of the COVID-19 Pandemic Among Minority Populations: My Family's Struggle to Survive.
    Acad Emerg Med. 2020 Oct 20. doi: 10.1111/acem.14154.
    PubMed         Abstract available

    AJR Am J Roentgenol

  2. CHEN L, Liang W
    Imaging Evaluation of Coronavirus Disease (COVID-19) Pneumonia in Pregnant Women.
    AJR Am J Roentgenol. 2020 Oct 14:W1. doi: 10.2214/AJR.20.24626.

  3. HANNA TN, Steenburg SD, Rosenkrantz AB, Pyatt RS Jr, et al
    Emerging Challenges and Opportunities in the Evolution of Teleradiology.
    AJR Am J Roentgenol. 2020 Oct 14:1-6. doi: 10.2214/AJR.20.23007.
    PubMed         Abstract available

    Am J Obstet Gynecol

  4. PATBERG ET, Adams T, Rekawek P, Vahanian SA, et al
    COVID-19 Infection and Placental Histopathology in Women Delivering at Term.
    Am J Obstet Gynecol. 2020 Oct 19. pii: S0002-9378(20)31194.
    PubMed         Abstract available

  5. MEYER R, Friedrich L, Maixner N, Bart Y, et al
    A marked decrease in Preterm Deliveries during the COVID-19 Pandemic.
    Am J Obstet Gynecol. 2020 Oct 15. pii: S0002-9378(20)31191.
    PubMed         Abstract available

    Am J Respir Crit Care Med

  6. SANFILIPPO F, La Rosa V, Oliveri F, Astuto M, et al
    COVID-19, Hypercoagulability and Cautiousness with Convalescent Plasma.
    Am J Respir Crit Care Med. 2020 Oct 21. doi: 10.1164/rccm.202008-3139.

  7. JHA AK
    Pulmonary Vascular Changes in Acute Respiratory Distress Syndrome Due to COVID-19.
    Am J Respir Crit Care Med. 2020 Oct 21. doi: 10.1164/rccm.202009-3508.

  8. ARACHCHILLAGE DJ, Desai SR, Devaraj A, Ridge CA, et al
    Reply to: Sanfilippo et al Caviedes et al.
    Am J Respir Crit Care Med. 2020 Oct 21. doi: 10.1164/rccm.202008-3340.

  9. CHEN L, Tang R, Chen H, Huang Y, et al
    Pulmonary Vasculature: A Target for COVID-19.
    Am J Respir Crit Care Med. 2020 Oct 21. doi: 10.1164/rccm.202009-3564.

  10. CAVIEDES I, Soto R, Torres A
    Pulmonary Angiopathy in Severe COVID-19: Physiological Conclusions Derived from Ventilatory Ratio?
    Am J Respir Crit Care Med. 2020 Oct 21. doi: 10.1164/rccm.202009-3446.

  11. ECHTERNACH M, Gantner S, Peters G, Westphalen C, et al
    Impulse Dispersion of Aerosols During Singing and Speaking: A Potential COVID-19 Transmission Pathway.
    Am J Respir Crit Care Med. 2020 Oct 16. doi: 10.1164/rccm.202009-3438.

  12. BATARSEH E, Kersten BP, Pinelo AC, Nadler JN, et al
    Angioedema in African Americans Patients Hospitalized for COVID-19.
    Am J Respir Crit Care Med. 2020 Oct 14. doi: 10.1164/rccm.202006-2223.

  13. PERIER F, Tuffet S, Maraffi T, Alcala G, et al
    Effect of PEEP and Proning on Ventilation and Perfusion in COVID-19 ARDS.
    Am J Respir Crit Care Med. 2020 Oct 19. doi: 10.1164/rccm.202008-3058.

  14. GATTINONI L, Marini JJ, Camporota L
    Reply to: Respiratory Drive Measurements do not Signify Conjectural P-SILI.
    Am J Respir Crit Care Med. 2020 Oct 16. doi: 10.1164/rccm.202009-3692.

  15. TOBIN MJ, Jubran A, Laghi F
    Respiratory Drive Measurements do not Signify Conjectural P-SILI.
    Am J Respir Crit Care Med. 2020 Oct 16. doi: 10.1164/rccm.202009-3630.

    Ann Intern Med

  16. SRINIVASAN M, Asch S, Vilendrer S, Thomas SC, et al
    Qualitative Assessment of Rapid System Transformation to Primary Care Video Visits at an Academic Medical Center.
    Ann Intern Med. 2020;173:527-535.
    PubMed         Abstract available

  17. WEISSMAN GE, Crane-Droesch A, Chivers C, Mikkelsen ME, et al
    Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic.
    Ann Intern Med. 2020;173:680-681.

  18. CLIFT AK, Coupland CAC, Keogh RH, Hemingway H, et al
    COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults.
    Ann Intern Med. 2020 Oct 21. doi: 10.7326/M20-4986.

  19. STERN RH
    Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic.
    Ann Intern Med. 2020;173:679-680.

  20. SACKS HS
    Accuracy of point-of-care diagnostic tests for SARS-CoV-2 antibodies (IgM/IgG) is heterogeneous.
    Ann Intern Med. 2020;173:JC47.
    PubMed         Abstract available

  21. SINGH A, Sonpar A
    In adults exposed to COVID-19, hydroxychloroquine did not reduce confirmed or probable COVID-19; trial stopped for futility.
    Ann Intern Med. 2020;173:JC41.
    PubMed         Abstract available

  22. Correction: Infection Fatality Ratios for COVID-19 Among Noninstitutionalized Persons 12 and Older.
    Ann Intern Med. 2020;173:684.

  23. LO B, Sim I
    Ethical Framework for Assessing Manual and Digital Contact Tracing for COVID-19.
    Ann Intern Med. 2020 Oct 20. doi: 10.7326/M20-5834.
    PubMed         Abstract available

  24. CHOU R, Dana T, Buckley DI, Selph S, et al
    Update Alert 5: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers.
    Ann Intern Med. 2020 Oct 20. doi: 10.7326/L20-1227.

  25. MEHROTRA DV, Janes HE, Fleming TR, Annunziato PW, et al
    Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
    Ann Intern Med. 2020 Oct 22. doi: 10.7326/M20-6169.
    PubMed         Abstract available

  26. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: What Physicians Need to Know.
    Ann Intern Med. 2020 Oct 20. doi: 10.7326/M20-6841.

  27. HERNANDEZ AV, Roman YM, Pasupuleti V, Barboza JJ, et al
    Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
    Ann Intern Med. 2020 Oct 21. doi: 10.7326/L20-1257.

    Antiviral Res

  28. CHOI SW, Shin JS, Park SJ, Jung E, et al
    Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
    Antiviral Res. 2020 Oct 19:104955. doi: 10.1016/j.antiviral.2020.104955.
    PubMed         Abstract available


  29. TAYLOR L
    Covid-19: Venezuela's doctors refuse to be gagged.
    BMJ. 2020;371:m3938.

  30. NACI H, Kesselheim AS, Rottingen JA, Salanti G, et al
    Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19.
    BMJ. 2020;371:m3869.

  31. RIMMER A
    Covid-19: Extend visas for international staff to help fight second wave, health unions urge.
    BMJ. 2020;371:m4041.

  32. WALSH S, Simmons-Jones F, Best R
    Care during covid-19: partner attendance at maternity services.
    BMJ. 2020;371:m3973.

  33. TANNE JH
    Covid-19: Fauci awarded for "unprecedented public service" while Trump fires more insults.
    BMJ. 2020;371:m4064.

  34. CAR J, Koh GC, Foong PS, Wang CJ, et al
    Video consultations in primary and specialist care during the covid-19 pandemic and beyond.
    BMJ. 2020;371:m3945.

  35. MCKEE M, Stuckler D
    Scientific divisions on covid-19: not what they might seem.
    BMJ. 2020;371:m4024.

  36. RIMMER A
    Increase medical workforce to tackle covid-19 backlog, doctors' leaders urge.
    BMJ. 2020;371:m4056.

  37. DAVEY SMITH G, Blastland M, Munafo M
    Covid-19's known unknowns.
    BMJ. 2020;371:m3979.

  38. CAESAR S, Layer G, Alexander R, Banks V, et al
    Appraisal needs to re-start now so doctors can reflect on coronavirus experiences.
    BMJ. 2020;371:m3987.

  39. O'DOWD A
    Covid-19 pandemic is magnifying healthcare inequalities, says England's regulator.
    BMJ. 2020;371:m4035.

  40. DYER O
    Covid-19: Remdesivir has little or no impact on survival, WHO trial shows.
    BMJ. 2020;371:m4057.

  41. MAHASE E
    Covid-19: Experts recommend two week circuit break to reduce transmission in the UK.
    BMJ. 2020;371:m4038.

    Covid-19: England's test and trace system records worst weekly performance since launch.
    BMJ. 2020;371:m4027.

    Covid-19: Shielding may be reintroduced for vulnerable people in highest risk areas.
    BMJ. 2020;371:m3969.

    Covid-19: Three tier alert system takes effect across England.
    BMJ. 2020;371:m3961.

  45. BUTLER M, Pollak TA, Rooney AG, Michael BD, et al
    Neuropsychiatric complications of covid-19.
    BMJ. 2020;371:m3871.

  46. WISE J
    Covid-19: Leading doctors argue against local lockdowns.
    BMJ. 2020;371:m3959.

  47. SPELSBERG A, Keil U
    Should we continue covid-19 suppression measures based on a transmission model that ignored pre-existing human immunity?
    BMJ. 2020;371:m3927.

  48. MAHASE E
    Covid-19: Johnson and Johnson vaccine trial is paused because of unexplained illness in participant.
    BMJ. 2020;371:m3967.

    The BMJ Interview: Tim Spector on how data can arm us against covid-19.
    BMJ. 2020;371:m3921.

  50. KURTH T, Brinks R
    Predicting the pandemic.
    BMJ. 2020;371:m3932.

  51. DYER O
    Covid-19: Eli Lilly pauses antibody trial for safety reasons.
    BMJ. 2020;371:m3985.

  52. HAM C
    Covid-19 exposes NHS fault lines in England.
    BMJ. 2020;371:m3922.

  53. LIMB M
    Covid-19: Liverpool's intensive care and critical care beds are "filling up fast," health leader warns.
    BMJ. 2020;371:m3977.

    Operation Moonshot: is it time to rein in the public health experts?
    BMJ. 2020;371:m3917.

  55. SPENCE D
    Covid-19 in Sweden and the UK: Risk, the Game of Life.
    BMJ. 2020;371:m4068.

  56. SPERRIN M, McMillan B
    Prediction models for covid-19 outcomes.
    BMJ. 2020;371:m3777.

    Covid-19: Empty chairs mark US deaths.
    BMJ. 2020;371:m3949.

  58. MAHASE E
    Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts.
    BMJ. 2020;371:m4042.

  59. TANNE JH
    Covid 19: Patients have many more complications than flu patients, finds US study.
    BMJ. 2020;371:m4106.

    Covid-19: Increased risk among ethnic minorities is largely due to poverty and social disparities, review finds.
    BMJ. 2020;371:m4099.

  61. AGARWAL A, Mukherjee A, Kumar G, Chatterjee P, et al
    Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).
    BMJ. 2020;371:m3939.
    PubMed         Abstract available

    Convalescent plasma is ineffective for covid-19.
    BMJ. 2020;371:m4072.

  63. MAHASE E
    Covid-19: Human challenge studies will see people purposefully infected with virus.
    BMJ. 2020;371:m4101.

  64. RIMMER A
    Covid-19: Most trainees have faced disruption to their training, GMC survey shows.
    BMJ. 2020;371:m4093.

  65. DOSHI P
    Will covid-19 vaccines save lives? Current trials aren't designed to tell us.
    BMJ. 2020;371:m4037.

  66. WISE J
    Covid-19: Suicidal thoughts increased in young adults during lockdown, UK study finds.
    BMJ. 2020;371:m4095.

    Covid-19 in Sweden and UK: medical leadership should energise wider debate.
    BMJ. 2020;371:m4066.

  68. CLIFT AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, et al
    Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.
    BMJ. 2020;371:m3731.
    PubMed         Abstract available

    Covid-19: Second wave death rate is doubling fortnightly but is lower and slower than in March.
    BMJ. 2020;371:m4092.

  70. MAHASE E
    Covid-19: Harshest restrictions are imposed on Greater Manchester after talks collapse.
    BMJ. 2020;371:m4084.

  71. OLIVER D
    David Oliver: How not to do covid-19 comms-copy our government.
    BMJ. 2020;371:m3986.

    What covid-19 and health insurance mean for the US election.
    BMJ. 2020;371:m3781.

  73. DOSHI P
    Covid-19 vaccine trial protocols released.
    BMJ. 2020;371:m4058.

    Clin Chem

  74. SUHANDYNATA RT, Hoffman MA, Huang D, Tran JT, et al
    Commercial Serology Assays Predict Neutralization Activity Against SARS-CoV-2.
    Clin Chem. 2020 Oct 21. pii: 5934505. doi: 10.1093.
    PubMed         Abstract available

    Clin Infect Dis

  75. RODRIGUEZ JY, Le Pape P, Lopez O, Esquea K, et al
    Candida auris: a latent threat to critically ill patients with COVID-19.
    Clin Infect Dis. 2020 Oct 18. pii: 5929667. doi: 10.1093/cid/ciaa1595.

  76. WHITE PL, Dhillon R, Healy B, Wise MP, et al
    Candidaemia in COVID-19, a link to disease pathology or increased clinical pressures?
    Clin Infect Dis. 2020 Oct 18. pii: 5929669. doi: 10.1093/cid/ciaa1597.

  77. RAJASINGHAM R, Bangdiwala AS, Nicol MR, Skipper CP, et al
    Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial.
    Clin Infect Dis. 2020 Oct 17. pii: 5929230. doi: 10.1093/cid/ciaa1571.
    PubMed         Abstract available

    An overlooked role for fecal transmission of SARS-CoV-2?
    Clin Infect Dis. 2020 Oct 16. pii: 5925219. doi: 10.1093/cid/ciaa1575.

  79. MCCAW ZR, Tian L, Kim DH, Localio AR, et al
    Survival analysis of treatment efficacy in comparative COVID-19 studies.
    Clin Infect Dis. 2020 Oct 14. pii: 5923375. doi: 10.1093/cid/ciaa1563.
    PubMed         Abstract available

  80. DU P, Song C, Li R, Song Y, et al
    Specific re-distribution of SARS-CoV-2 variants in the respiratory system and intestinal tract.
    Clin Infect Dis. 2020 Oct 22. pii: 5934821. doi: 10.1093/cid/ciaa1617.
    PubMed         Abstract available

  81. SACHITHANANDHAM J, Thio CL, Balagopal A
    The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Composite But Incomplete Picture.
    Clin Infect Dis. 2020 Sep 29. pii: 5912956. doi: 10.1093/cid/ciaa1413.

  82. ASLAM A, Singh J, Robilotti E, Chow K, et al
    SARS CoV-2 Surveillance and Exposure in the Perioperative Setting with Universal testing and Personal Protective Equipment (PPE) Policies.
    Clin Infect Dis. 2020 Oct 22. pii: 5934921. doi: 10.1093/cid/ciaa1607.
    PubMed         Abstract available

  83. OLDONI E, van Gool A, Garcia Bermejo L, Scherer A, et al
    Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination.
    Clin Infect Dis. 2020 Oct 22. pii: 5935756. doi: 10.1093/cid/ciaa1250.
    PubMed         Abstract available

    Transmission of SARS-CoV-2 via Contaminated Surfaces: What is to be Done?
    Clin Infect Dis. 2020 Oct 18. pii: 5929662. doi: 10.1093/cid/ciaa1586.

  85. PIMENOFF VN, Elfstrom M, Baussano I, Bjornstedt M, et al
    Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden.
    Clin Infect Dis. 2020 Oct 18. pii: 5929661. doi: 10.1093/cid/ciaa1593.
    PubMed         Abstract available

  86. KOJIMA N, Turner F, Slepnev V, Bacelar A, et al
    Self-Collected Oral Fluid and Nasal Swab Specimens Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swab Specimens for the Detection of SARS-CoV-2.
    Clin Infect Dis. 2020 Oct 19. pii: 5930814. doi: 10.1093/cid/ciaa1589.
    PubMed         Abstract available

  87. ANESI GL
    Hospital transfers across U.S. regions to address the "space" shortage in a pandemic: a public good.
    Clin Infect Dis. 2020 Oct 18. pii: 5929668. doi: 10.1093/cid/ciaa1596.

  88. DAUBY N
    Favipiravir as an antiviral agent in COVID-19: same script, different cast?
    Clin Infect Dis. 2020 Oct 19. pii: 5930653. doi: 10.1093/cid/ciaa1600.

  89. YANG B, Fulcher JA, Ahn J, Berro M, et al
    Clinical Characteristics and Outcomes of COVID-19 Patients Receiving Compassionate Use Leronlimab.
    Clin Infect Dis. 2020 Oct 20. pii: 5932277. doi: 10.1093/cid/ciaa1583.
    PubMed         Abstract available

  90. XU J, Teng Y, Shang L, Gu X, et al
    The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2020 Oct 20. pii: 5932274. doi: 10.1093/cid/ciaa1592.
    PubMed         Abstract available

  91. O'DRISCOLL M, Harry C, Donnelly CA, Cori A, et al
    A comparative analysis of statistical methods to estimate the reproduction number in emerging epidemics with implications for the current COVID-19 pandemic.
    Clin Infect Dis. 2020 Oct 20. pii: 5932264. doi: 10.1093/cid/ciaa1599.
    PubMed         Abstract available

  92. LEI H, Wu X, Wang X, Xu M, et al
    Different transmission dynamics of COVID-19 and influenza suggest the relative efficiency of isolation/quarantine and social distancing against COVID-19 in China.
    Clin Infect Dis. 2020 Oct 20. pii: 5932276. doi: 10.1093/cid/ciaa1584.
    PubMed         Abstract available

  93. AZZI L
    Saliva is the Key Element for SARS-CoV-2 Mass Screening.
    Clin Infect Dis. 2020 Oct 21. pii: 5933821. doi: 10.1093/cid/ciaa1440.

  94. AHMAD MF, Mahakkanukrauh P, Das S
    The detection of SARS-CoV-2 virus in the vaginal fluid of females with severe COVID-19 infection: scientific facts.
    Clin Infect Dis. 2020 Oct 21. pii: 5934738. doi: 10.1093/cid/ciaa1608.

  95. GERETTI AM, Stockdale AJ, Kelly SH, Cevik M, et al
    Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study.
    Clin Infect Dis. 2020 Oct 23. pii: 5937133. doi: 10.1093/cid/ciaa1605.
    PubMed         Abstract available

  96. YOSHIOKA T, Funada S, Luo Y
    The inherent problems with the generalizability of the CALL score: towards reliable clinical prediction models for COVID-19.
    Clin Infect Dis. 2020 Oct 16. pii: 5925185. doi: 10.1093/cid/ciaa1564.

    Emerg Infect Dis

  97. JOSEPH NT, Stanhope KK, Badell ML, Horton JP, et al
    Sociodemographic Predictors of SARS-CoV-2 Infection in Obstetric Patients, Georgia, USA.
    Emerg Infect Dis. 2020;26:2787-2789.
    PubMed         Abstract available

  98. CHAU NVV, Hong NTT, Ngoc NM, Thanh TT, et al
    Superspreading Event of SARS-CoV-2 Infection at a Bar, Ho Chi Minh City, Vietnam.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  99. WALTENBURG MA, Rose CE, Victoroff T, Butterfield M, et al
    Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture Workplaces.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  100. GUZZETTA G, Riccardo F, Marziano V, Poletti P, et al
    Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  101. MARR KA, Platt A, Tornheim JA, Zhang SX, et al
    Aspergillosis Complicating Severe Coronavirus Disease.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  102. SCHWARZKOPF S, Krawczyk A, Knop D, Klump H, et al
    Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  103. FREULING CM, Breithaupt A, Muller T, Sehl J, et al
    Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection.
    Emerg Infect Dis. 2020;26.
    PubMed         Abstract available

  104. DIA N, Lakh NA, Diagne MM, Mbaye KD, et al
    COVID-19 Outbreak, Senegal, 2020.
    Emerg Infect Dis. 2020;26:2772-2774.
    PubMed         Abstract available

  105. CHOE PG, Kang CK, Suh HJ, Jung J, et al
    Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  106. CHAN PKS, Lui G, Hachim A, Ko RLW, et al
    Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020.
    Emerg Infect Dis. 2020;26.
    PubMed         Abstract available

    Eur J Radiol

  107. YU T
    COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer.
    Eur J Radiol. 2020;132:109338.
    PubMed         Abstract available

  108. OOI MWX, Rajai A, Patel R, Gerova N, et al
    Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer.
    Eur J Radiol. 2020;132:109336.
    PubMed         Abstract available

  109. COLOMBI D, Petrini M, Maffi G, Villani GD, et al
    Comparison of admission chest computed tomography and lung ultrasound performance for diagnosis of COVID-19 pneumonia in populations with different disease prevalence.
    Eur J Radiol. 2020;133:109344.
    PubMed         Abstract available

    Infect Control Hosp Epidemiol

  110. DIERINGER TD, Furukawa D, Graber CJ, Stevens VW, et al
    Inpatient antibiotic utilization in the Veterans Administration during the COVID-19 pandemic.
    Infect Control Hosp Epidemiol. 2020 Oct 20:1-9. doi: 10.1017/ice.2020.1277.
    PubMed         Abstract available

  111. MENA LORA AJ, Ali M, Krill C, Borgetti SA, et al
    Feasibility and impact of inverted classroom methodology for COVID-19 pandemic preparedness at an urban community hospital.
    Infect Control Hosp Epidemiol. 2020 Oct 20:1-9. doi: 10.1017/ice.2020.1272.

  112. MILLER J, Opat S, Shortt J, Kotsanas D, et al
    Impact of COVID-19 Pandemic Isolation Measures on the Rate of Non-COVID Infections in Hematology Patients.
    Infect Control Hosp Epidemiol. 2020 Oct 20:1-10. doi: 10.1017/ice.2020.1279.

  113. FONTANA L, Villamagna AH, Sikka MK, McGregor JC, et al
    Understanding Viral Shedding of SARS-CoV-2: Review of Current Literature.
    Infect Control Hosp Epidemiol. 2020 Oct 20:1-35. doi: 10.1017/ice.2020.1273.
    PubMed         Abstract available

  114. ONG SWX, Lee PH, Tan YK, Ling LM, et al
    Environmental contamination in a COVID-19 intensive care unit (ICU) - what is the risk?
    Infect Control Hosp Epidemiol. 2020 Oct 21:1-28. doi: 10.1017/ice.2020.1278.
    PubMed         Abstract available

  115. MURTHY AR, Hanrahan JA, Advani SD, Ashraf MS, et al
    State of the Pandemic Commentary: Preparing Nursing Homes for a Second Wave of COVID-19.
    Infect Control Hosp Epidemiol. 2020 Oct 20:1-9. doi: 10.1017/ice.2020.1283.

    Int J Infect Dis

  116. MALVIYA A
    The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.
    Int J Infect Dis. 2020;99:310-311.

  117. MADSEN LW, Lindvig SO, Rasmussen LD, Knudtzen FC, et al
    Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital setting.
    Int J Infect Dis. 2020 Oct 12. pii: S1201-9712(20)32221.
    PubMed         Abstract available

  118. MOHANA A, Sulaiman T, Mahmoud N, Hassanein M, et al
    Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32235.
    PubMed         Abstract available

  119. NG CFS, Seposo XT, Moi ML, Tajudin MABA, et al
    Characteristics of COVID-19 epidemic and control measures to curb transmission in Malaysia.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32231.
    PubMed         Abstract available

  120. STAADEGAARD L, Taylor RJ, Spreeuwenberg P, Caini S, et al
    Monitoring the mortality impact of COVID-19 in Europe: What can be learned from 2009 influenza H1N1p mortality studies?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32241.
    PubMed         Abstract available

  121. DAUBY N, Bottieau E
    The unfinished story of hydroxychloroquine in COVID-19: the right anti-inflammatory dose at the right moment?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32236.

  122. BAECK M, Herman A
    COVID toes: where do we stand with the current evidence?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32225.
    PubMed         Abstract available

  123. MOHAMMAD A, Alshawaf E, Marafie SK, Abu-Farha M, et al
    Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32237.
    PubMed         Abstract available

  124. ABAYOMI A, Odukoya O, Osibogun A, Wright O, et al
    Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32228.
    PubMed         Abstract available

  125. LAWAL Y
    Africa's low COVID-19 mortality rate: A paradox?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32242.
    PubMed         Abstract available

  126. HERZBERG J, Vollmer T, Fischer B, Becher H, et al
    A Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32230.
    PubMed         Abstract available

  127. VELAVAN TP, Meyer CG
    Reply to: Asymptomatic infection by SARS 2 coronavirus: invisible but invincible.
    Int J Infect Dis. 2020 Oct 17. pii: S1201-9712(20)32238.

  128. VENUGOPAL U, Jilani N, Rabah S, Shariff MA, et al
    SARS-CoV-2 Seroprevalence Among Health Care Workers in a New York City Hospital: A Cross-Sectional Analysis During the COVID-19 Pandemic.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32240.
    PubMed         Abstract available

  129. NAKAMOTO T, Ishikane M, Sasaki R, Ohmagari N, et al
    Periungual desquamation in a Japanese Adult recovering from severe COVID-19.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32233.
    PubMed         Abstract available

    Intensive Care Med

  130. Differences in clinical deterioration among three sub-phenotypes of COVID-19 patients at the time of first positive test: results from a clustering analysis.
    Intensive Care Med. 2020 Oct 19. pii: 10.1007/s00134-020-06236.

  131. DE WAELE JJ, Derde L, Bassetti M
    Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?
    Intensive Care Med. 2020 Oct 17. pii: 10.1007/s00134-020-06278.

  132. DE JONG A, Wrigge H, Hedenstierna G, Gattinoni L, et al
    How to ventilate obese patients in the ICU.
    Intensive Care Med. 2020 Oct 23. pii: 10.1007/s00134-020-06286.
    PubMed         Abstract available

  133. CHIUMELLO D, Busana M, Coppola S, Romitti F, et al
    Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study.
    Intensive Care Med. 2020 Oct 21. pii: 10.1007/s00134-020-06281.
    PubMed         Abstract available

  134. CARTER MJ, Shankar-Hari M, Tibby SM
    Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview.
    Intensive Care Med. 2020 Oct 14. pii: 10.1007/s00134-020-06273.

    J Infect

  135. WELLS PM, Doores KJ, Couvreur S, Nunez RM, et al
    Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.
    J Infect. 2020 Oct 14. pii: S0163-4453(20)30653.
    PubMed         Abstract available

    J Med Virol

  136. WU S, Tian C, Liu P, Guo D, et al
    Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26597.
    PubMed         Abstract available

  137. ROSEN HR, O'Connell C, Nadim MK, DeClerck B, et al
    Extrapulmonary Manifestations of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26595.
    PubMed         Abstract available

  138. SREENIVASAN CC, Thomas M, Wang D, Li F, et al
    Susceptibility of livestock and companion animals to COVID-19.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26621.
    PubMed         Abstract available

  139. TAKAGI H
    Presidential vote 2016 and COVID-19 epidemic.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26620.
    PubMed         Abstract available

  140. BWIRE GM, Njiro BJ, Mwakawanga DL, Sabas D, et al
    Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: A living systematic review.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26622.
    PubMed         Abstract available

  141. HE J, Huang F, Zhang J, Chen Q, et al
    Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26596.
    PubMed         Abstract available

  142. SHAMINUR RAHMAN M, Rafiul Islam M, Rubayet Ul Alam ASM, Islam I, et al
    Evolutionary dynamics of SARS-CoV-2 nucleocapsid (N) protein and its consequences.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26626.
    PubMed         Abstract available

  143. BAIG AM
    Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26624.
    PubMed         Abstract available

  144. WANG Y, Chen B, Li Y, Zhang L, et al
    The Use of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors is Associated with a Lower Risk of Mortality in Hypertensive COVID-19 Patients: A Systematic Review and Meta-analysis.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26625.
    PubMed         Abstract available

  145. HIGUCHI T, Nishida T, Iwahashi H, Morimura O, et al
    Early Clinical Factors Predicting the Development of Critical Disease in Japanese Patients with COVID-19: A Single-Center, Retrospective, Observational Study.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26599.
    PubMed         Abstract available

  146. MOHANTY S, Ravindra A, Gupta K, Hallur V, et al
    Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26618.
    PubMed         Abstract available

  147. CHEN Y, Ke Y, Liu X, Wang Z, et al
    Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26617.
    PubMed         Abstract available

    Impact on disease mortality of clinical, biological and virological characteristics at hospital admission and over time in COVID-19 patients.
    J Med Virol. 2020 Oct 15. doi: 10.1002/jmv.26601.
    PubMed         Abstract available

  149. SILVA JUNIOR JVJ, Lopes TRR, Weiblen R, Flores EF, et al
    Background immunity: how important is it for SARS-CoV-2?
    J Med Virol. 2020 Oct 15. doi: 10.1002/jmv.26602.
    PubMed         Abstract available

  150. YIGENOGLU TN, Basci S, Sinan Dal M, Korkmaz S, et al
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 16. doi: 10.1002/jmv.26607.
    PubMed         Abstract available

  151. CRISCUOLO E, Diotti RA, Strollo M, Rolla S, et al
    Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects.
    J Med Virol. 2020 Oct 16. doi: 10.1002/jmv.26605.
    PubMed         Abstract available

  152. STRATTON CW, Tang YW, Lu H
    Pathogenesis-Directed Therapy of 2019 Novel Coronavirus Disease.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26610.
    PubMed         Abstract available

  153. YANG P, Wang N, Wang J, Luo A, et al
    Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26608.
    PubMed         Abstract available

  154. CAVALIERE AF, Marchi L, Aquilini D, Brunelli T, et al
    Passive Immunity in Newborn from SARS-CoV-2 Infected Mother.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26609.
    PubMed         Abstract available

  155. YUN HE, Ryu BY, Choe YJ
    Impact of Social Distancing on Incidence of Vaccine-Preventable Diseases, South Korea.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26614.
    PubMed         Abstract available

  156. SELINGEROVA I, Valik D, Gescheidtova L, Sramek V, et al
    Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26612.
    PubMed         Abstract available

  157. KIVELA JM, Jarva H, Lappalainen M, Kurkela S, et al
    Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26613.
    PubMed         Abstract available

  158. KUMAR A, Prasoon P, Kumari C, Pareek V, et al
    SARS-CoV-2 specific virulence factors in COVID-19.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26615.
    PubMed         Abstract available

  159. MATTOS EC, Matsuda EM, Colpas DR, Carvalho F, et al
    Can urine be a potential biohazard in times of SARS-CoV-2 pandemic?
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26616.
    PubMed         Abstract available

  160. PODDER S, Ghosh A, Ghosh T
    Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26598.
    PubMed         Abstract available

    J Thorac Oncol

  161. KIDANE B, Levin DP
    Identification and Resolution of Asymptomatic COVID-19 Pneumonitis and Colitis: Serial Assessment of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Evaluation of Lung Cancer.
    J Thorac Oncol. 2020 Oct 5. pii: S1556-0864(20)30725.

    J Travel Med

  162. CHU IY, Alam P, Larson H, Lin L, et al
    Social consequences of mass quarantine during epidemics: a systematic review with implications for the COVID-19 response.
    J Travel Med. 2020 Oct 13. pii: 5922349. doi: 10.1093.
    PubMed         Abstract available

  163. WENG CH, Chan PA
    BCG as an adjunct or alternative vaccine to prevent COVID-19?
    J Travel Med. 2020 Sep 19. pii: 5908817. doi: 10.1093.

  164. YANG J, Li J, Lai S, Ruktanonchai CW, et al
    Uncovering two phases of early intercontinental COVID-19 transmission dynamics.
    J Travel Med. 2020 Oct 22. pii: 5935386. doi: 10.1093.
    PubMed         Abstract available

  165. AFEK A, Leshem E, Kaliner E, Fast D, et al
    Upholding democracy in a global pandemic: the Israeli elections experience.
    J Travel Med. 2020 Sep 15. pii: 5905946. doi: 10.1093.

    J Virol

  166. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    PubMed         Abstract available


  167. ANGUS DC
    Optimizing the Trade-off Between Learning and Doing in a Pandemic.
    JAMA. 2020;323:1895-1896.

  168. SARPATWARI A, Kaltenboeck A, Kesselheim AS
    Missed Opportunities on Emergency Remdesivir Use.
    JAMA. 2020;324:331-332.

    "Are You Wearing Your White Coat?": Telemedicine in the Time of Pandemic.
    JAMA. 2020;324:149-150.

  170. MARKS PW, Hahn S
    Identifying the Risks of Unproven Regenerative Medicine Therapies.
    JAMA. 2020;324:241-242.

  171. SERAFEIM G, Rischbieth AM, Koh HK
    Sustainability, Business, and Health.
    JAMA. 2020;324:147-148.

  172. LEE GM, Bell BP, Romero JR
    The Advisory Committee on Immunization Practices and Its Role in the Pandemic Vaccine Response.
    JAMA. 2020 Jul 22. pii: 2768852. doi: 10.1001/jama.2020.13167.

  173. CUTLER D
    New Rules for the Pandemic Era.
    JAMA. 2020;324:1023-1024.

  174. WOLINETZ CD, Collins FS
    Recognition of Research Participants' Need for Autonomy: Remembering the Legacy of Henrietta Lacks.
    JAMA. 2020;324:1027-1028.

  175. ABBASI J
    Portable MRI-Coming to the ICU?
    JAMA. 2020;324:1386.

  176. LEVITT L
    Trump vs Biden on Health Care.
    JAMA. 2020;324:1384-1385.

  177. SAAG MS, Gandhi RT, Hoy JF, Landovitz RJ, et al
    Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
    JAMA. 2020 Oct 14. pii: 2771873. doi: 10.1001/jama.2020.17025.
    PubMed         Abstract available

  178. SCHMIDT H, Gostin LO, Williams MA
    Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    JAMA. 2020 Oct 14. pii: 2771874. doi: 10.1001/jama.2020.20571.

  179. ABBASI J
    Large Meta-analysis Digs Into Obesity's COVID-19 Risks.
    JAMA. 2020 Oct 15. pii: 2772071. doi: 10.1001/jama.2020.18637.

  180. SEYMOUR CW, McCreary EK, Stegenga J
    Sensible Medicine-Balancing Intervention and Inaction During the COVID-19 Pandemic.
    JAMA. 2020 Oct 15. pii: 2772072. doi: 10.1001/jama.2020.20271.

  181. VOLPP KG, Diamond SM, Shrank WH
    Innovation in Home Care: Time for a New Payment Model.
    JAMA. 2020;323:2474-2475.

  182. HUYNH PP, Ishii LE, Ishii M
    What Is Anosmia?
    JAMA. 2020;324:206.

  183. MCCORMACK G, Avery C, Spitzer AK, Chandra A, et al
    Economic Vulnerability of Households With Essential Workers.
    JAMA. 2020;324:388-390.

  184. OWEN WF JR, Carmona R, Pomeroy C
    Failing Another National Stress Test on Health Disparities.
    JAMA. 2020;323:1905-1906.

  185. FELDMAN O, Meir M, Shavit D, Idelman R, et al
    Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment.
    JAMA. 2020;323:2091-2093.

    Lost Space.
    JAMA. 2020;323:2019-2020.

    Choices for the "New Normal".
    JAMA. 2020;323:2125-2126.

    Surgery in a Time of Uncertainty: A Need for Universal Respiratory Precautions in the Operating Room.
    JAMA. 2020;323:2254-2255.

  189. ISON MG, Wolfe C, Boucher HW
    Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    JAMA. 2020;323:2365-2366.

  190. BUNYAVANICH S, Do A, Vicencio A
    Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.
    JAMA. 2020;323:2427-2429.

  191. TOLLES J, Luong T
    Modeling Epidemics With Compartmental Models.
    JAMA. 2020;323:2515-2516.

  192. RODRIGUEZ JA, Clark CR, Bates DW
    Digital Health Equity as a Necessity in the 21st Century Cures Act Era.
    JAMA. 2020;323:2381-2382.

  193. SONG Z
    Potential Implications of Lowering the Medicare Eligibility Age to 60.
    JAMA. 2020;323:2472-2473.

  194. SHARFSTEIN JM, Morphew CC
    The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020.
    JAMA. 2020;324:133-134.

  195. DESAI AN
    Artificial Intelligence: Promise, Pitfalls, and Perspective.
    JAMA. 2020;323:2448-2449.

  196. RUBIN R
    COVID-19's Crushing Effects on Medical Practices, Some of Which Might Not Survive.
    JAMA. 2020;324:321-323.

  197. PATEL MM, Jackson ML, Ferdinands J
    Postlicensure Evaluation of COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772136. doi: 10.1001/jama.2020.19328.

  198. GOODMAN JL, Grabenstein JD, Braun MM
    Answering Key Questions About COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772138. doi: 10.1001/jama.2020.20590.

  199. SHACHAR C, Engel J, Elwyn G
    Implications for Telehealth in a Postpandemic Future: Regulatory and Privacy Issues.
    JAMA. 2020;323:2375-2376.

  200. BELL BP, Romero JR, Lee GM
    Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.
    JAMA. 2020 Oct 22. pii: 2772326. doi: 10.1001/jama.2020.20847.

  201. RUBIN R
    The Challenges of Expanding Rapid Tests to Curb COVID-19.
    JAMA. 2020 Oct 21. pii: 2772299. doi: 10.1001/jama.2020.21106.

  202. KUEHN BM
    COVID-19 Halts Reproductive Care for Millions of Women.
    JAMA. 2020;324:1489.

  203. OMER SB, Yildirim I, Forman HP
    Herd Immunity and Implications for SARS-CoV-2 Control.
    JAMA. 2020 Oct 19. pii: 2772167. doi: 10.1001/jama.2020.20892.

  204. LEE GM, Romero JR, Bell BP
    Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
    JAMA. 2020 Oct 16. pii: 2772137. doi: 10.1001/jama.2020.19692.


  205. ALLOTEY P, Denton F
    Challenges and priorities for delivering on the Beijing Declaration and Platform for Action 25 years on.
    Lancet. 2020;396:1053-1055.

  206. FRUMKIN H, Myers SS
    Planetary health and the 2020 US election.
    Lancet. 2020;396:1048-1050.

    Mental health: time to invest in quality.
    Lancet. 2020;396:1045.

  208. HONIGSBAUM M, Krishnan L
    Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers.
    Lancet. 2020 Oct 12. pii: S0140-6736(20)32134.

  209. POLAND GA, Ovsyannikova IG, Kennedy RB
    SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32137.
    PubMed         Abstract available

  210. USUELLI M
    The Lombardy region of Italy launches the first investigative COVID-19 commission.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32154.

  211. PETO J, Hunter DJ, Riboli E, Griffin JL, et al
    Unnecessary obstacles to COVID-19 mass testing.
    Lancet. 2020 Oct 16. pii: S0140-6736(20)32170.

  212. PAES-SOUSA R, Millett C, Rocha R, Barreto ML, et al
    Science misuse and polarised political narratives in the COVID-19 response.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32168.

  213. FERIGATO S, Fernandez M, Amorim M, Ambrogi I, et al
    The Brazilian Government's mistakes in responding to the COVID-19 pandemic.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32164.

  214. STEWART R, El-Harakeh A, Cherian SA
    Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32141.

  215. ALWAN NA, Burgess RA, Ashworth S, Beale R, et al
    Scientific consensus on the COVID-19 pandemic: we need to act now.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32153.

    Lancet Child Adolesc Health

  216. SWAIN K
    Coping with more than COVID-19.
    Lancet Child Adolesc Health. 2020;4:806.

    Lancet Glob Health

  217. MANABE YC, Mashalla Y, Farquhar C, Sewankambo NK, et al
    Leadership training to accelerate progress in public health in sub-Saharan Africa: time for action.
    Lancet Glob Health. 2020;8:e1253-e1254.

  218. KEDDY KH, Migliori GB, Van Der Walt M
    Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis.
    Lancet Glob Health. 2020;8:e1357-e1358.

    Violations of independence: ethnicity and COVID-19 in Brazil.
    Lancet Glob Health. 2020 Oct 16. pii: S2214-109X(20)30431.

  220. RAKOTOSAMIMANANA N, Randrianirina F, Randremanana R, Raherison MS, et al
    GeneXpert for the diagnosis of COVID-19 in LMICs.
    Lancet Glob Health. 2020 Oct 19. pii: S2214-109X(20)30428.

    Lancet Infect Dis

  221. ISAKOVA-SIVAK I, Rudenko L
    A promising inactivated whole-virion SARS-CoV-2 vaccine.
    Lancet Infect Dis. 2020 Oct 15. pii: S1473-3099(20)30832.

  222. IWASAKI A
    What reinfections mean for COVID-19.
    Lancet Infect Dis. 2020 Oct 12. pii: S1473-3099(20)30783.

  223. TILLETT RL, Sevinsky JR, Hartley PD, Kerwin H, et al
    Genomic evidence for reinfection with SARS-CoV-2: a case study.
    Lancet Infect Dis. 2020 Oct 12. pii: S1473-3099(20)30764.
    PubMed         Abstract available

  224. XIA S, Zhang Y, Wang Y, Wang H, et al
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Lancet Infect Dis. 2020 Oct 15. pii: S1473-3099(20)30831.
    PubMed         Abstract available

  225. BROWN RCH, Kelly D, Wilkinson D, Savulescu J, et al
    The scientific and ethical feasibility of immunity passports.
    Lancet Infect Dis. 2020 Oct 16. pii: S1473-3099(20)30766.
    PubMed         Abstract available

  226. YANG W, Kandula S, Huynh M, Greene SK, et al
    Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Lancet Infect Dis. 2020 Oct 19. pii: S1473-3099(20)30769.
    PubMed         Abstract available

    Lancet Psychiatry

  227. OLDHAM MA, Slooter AJC, Cunningham C, Rahman S, et al
    Characterising neuropsychiatric disorders in patients with COVID-19.
    Lancet Psychiatry. 2020;7:932-933.

  228. VARATHARAJ A, Pollak TA, Nicholson TR, Coles JP, et al
    Characterising neuropsychiatric disorders in patients with COVID-19 - Authors' reply.
    Lancet Psychiatry. 2020;7:934-935.

  229. WADE D, Howell D, Beadman M, Quigley A, et al
    Characterising neuropsychiatric disorders in patients with COVID-19.
    Lancet Psychiatry. 2020;7:933-934.

    COVID-19 policies in the UK and consequences for mental health.
    Lancet Psychiatry. 2020 Oct 15. pii: S2215-0366(20)30457.

  231. JAGUGA F, Kiburi SK
    Reducing alcohol misuse during the COVID-19 pandemic in Kenya.
    Lancet Psychiatry. 2020;7:935-936.

    Lancet Respir Med

  232. BANGASH MN, Owen A, Alderman JE, Chotalia M, et al
    COVID-19 recovery: potential treatments for post-intensive care syndrome.
    Lancet Respir Med. 2020 Oct 12. pii: S2213-2600(20)30457.

    Obstructive sleep apnoea: latest surgical advances and considerations during the COVID-19 pandemic.
    Lancet Respir Med. 2020 Oct 16. pii: S2213-2600(20)30464.

  234. NAKSHBANDI G, Moor CC, Wijsenbeek MS
    Home monitoring for patients with ILD and the COVID-19 pandemic.
    Lancet Respir Med. 2020 Oct 16. pii: S2213-2600(20)30452.

  235. WOOLVEN S
    A call for Essays: stories from the frontline during the COVID-19 pandemic.
    Lancet Respir Med. 2020 Oct 13. pii: S2213-2600(20)30463.

  236. LEISMAN DE, Ronner L, Pinotti R, Taylor MD, et al
    Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.
    Lancet Respir Med. 2020 Oct 16. pii: S2213-2600(20)30404.
    PubMed         Abstract available

    Life Sci

  237. BAILLY C, Vergoten G
    Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis.
    Life Sci. 2020 Oct 18:118601. doi: 10.1016/j.lfs.2020.118601.
    PubMed         Abstract available

  238. MORRIS G, Bortolasci CC, Puri BK, Olive L, et al
    Preventing the development of severe CoVID 19 by modifying immunothrombosis.
    Life Sci. 2020 Oct 20:118617. doi: 10.1016/j.lfs.2020.118617.
    PubMed         Abstract available

    MMWR Morb Mortal Wkly Rep

  239. CATES J, Lucero-Obusan C, Dahl RM, Schirmer P, et al
    Risk for In-Hospital Complications Associated with COVID-19 and Influenza - Veterans Health Administration, United States, October 1, 2018-May 31, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1528-1534.
    PubMed         Abstract available

  240. ROSSEN LM, Branum AM, Ahmad FB, Sutton P, et al
    Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity - United States, January 26-October 3, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1522-1527.
    PubMed         Abstract available

  241. OSTER AM, Caruso E, DeVies J, Hartnett KP, et al
    Transmission Dynamics by Age Group in COVID-19 Hotspot Counties - United States, April-September 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1494-1496.
    PubMed         Abstract available

  242. CZEISLER ME, Garcia-Williams AG, Molinari NA, Gharpure R, et al
    Demographic Characteristics, Experiences, and Beliefs Associated with Hand Hygiene Among Adults During the COVID-19 Pandemic - United States, June 24-30, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1485-1491.
    PubMed         Abstract available

  243. ATRUBIN D, Wiese M, Bohinc B
    An Outbreak of COVID-19 Associated with a Recreational Hockey Game - Florida, June 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1492-1493.
    PubMed         Abstract available

  244. WILSON RF, Sharma AJ, Schluechtermann S, Currie DW, et al
    Factors Influencing Risk for COVID-19 Exposure Among Young Adults Aged 18-23 Years - Winnebago County, Wisconsin, March-July 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1497-1502.
    PubMed         Abstract available

  245. HONG SY, Ashipala LSN, Bikinesi L, Hamunime N, et al
    Rapid Adaptation of HIV Treatment Programs in Response to COVID-19 - Namibia, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1549-1551.
    PubMed         Abstract available

  246. CHIPIMO PJ, Barradas DT, Kayeyi N, Zulu PM, et al
    First 100 Persons with COVID-19 - Zambia, March 18-April 28, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1547-1548.
    PubMed         Abstract available

  247. HILL HA, Yankey D, Elam-Evans LD, Singleton JA, et al
    Vaccination Coverage by Age 24 Months Among Children Born in 2016 and 2017 - National Immunization Survey-Child, United States, 2017-2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:1505-1511.
    PubMed         Abstract available

  248. GOLD JAW, Rossen LM, Ahmad FB, Sutton P, et al
    Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 - United States, May-August 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1517-1521.
    PubMed         Abstract available

  249. MURRAY MT, Riggs MA, Engelthaler DM, Johnson C, et al
    Mitigating a COVID-19 Outbreak Among Major League Baseball Players - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1542-1546.
    PubMed         Abstract available

  250. DASGUPTA S, Bowen VB, Leidner A, Fletcher K, et al
    Association Between Social Vulnerability and a County's Risk for Becoming a COVID-19 Hotspot - United States, June 1-July 25, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1535-1541.
    PubMed         Abstract available

    N Engl J Med

  251. BELOT A, Levy-Bruhl D
    Multisystem Inflammatory Syndrome in Children in the United States.
    N Engl J Med. 2020;383.

  252. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinology and Covid-19.
    N Engl J Med. 2020;383:e109.

  253. KASER A
    Genetic Risk of Severe Covid-19.
    N Engl J Med. 2020;383:1590-1591.

  254. WALSH EE, Frenck RW Jr, Falsey AR, Kitchin N, et al
    Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMoa2027906.
    PubMed         Abstract available

  255. SHAPIRO J, McDonald TB
    Supporting Clinicians during Covid-19 and Beyond - Learning from Past Failures and Envisioning New Strategies.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMp2024834.

  256. Dying in a Leadership Vacuum.
    N Engl J Med. 2020;383:1479-1480.

  257. CUNEO CN, Janeway H
    From Icebox to Tinderbox - A View from the Southern Border.
    N Engl J Med. 2020;383:e81.

  258. RAFIEI Y, Mello MM
    The Missing Piece - SARS-CoV-2 Testing and School Reopening.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2028209.

  259. STONE JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, et al
    Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMoa2028836.
    PubMed         Abstract available

  260. CHOWDHURY JF, Moores LK, Connors JM
    Anticoagulation in Hospitalized Patients with Covid-19.
    N Engl J Med. 2020;383:1675-1678.

  261. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Tocilizumab and Covid-19.
    N Engl J Med. 2020;383:e114.

  262. STRASSLE C, Jardas E, Ochoa J, Berkman BE, et al
    Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2025955.

  263. GOODING R, Myers B, Salta S
    Lupus Anticoagulant in Patients with Covid-19.
    N Engl J Med. 2020;383.

  264. PLATTON S, Bowles L, Pasi KJ
    Lupus Anticoagulant in Patients with Covid-19. Reply.
    N Engl J Med. 2020;383.

  265. BROSSEAU LM, Roy CJ, Osterholm MT
    Facial Masking for Covid-19.
    N Engl J Med. 2020;383.

  266. GANDHI M, Rutherford GW
    Facial Masking for Covid-19. Reply.
    N Engl J Med. 2020;383.

  267. HATA SR
    The Ritual of the Table.
    N Engl J Med. 2020;383:1301-1303.

  268. RASMUSSEN AL, Escandon K, Popescu SV
    Facial Masking for Covid-19.
    N Engl J Med. 2020;383.

  269. WARREN RC, Forrow L, Hodge DA Sr, Truog RD, et al
    Trustworthiness before Trust - Covid-19 Vaccine Trials and the Black Community.
    N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2030033.


    The false promise of herd immunity for COVID-19.
    Nature. 2020 Oct 21. pii: 10.1038/d41586-020-02948.

    How anti-ageing drugs could boost COVID vaccines in older people.
    Nature. 2020;586:352-354.

  272. ENDESFELDER U, Pfluger D, de Wolff T
    #StopPandemicBias: scientists, share your privilege.
    Nature. 2020;583:683.

    Signs of depression and anxiety soar among US graduate students during pandemic.
    Nature. 2020;585:147-148.

  274. SAMPSON C, Vamosi SM
    Don't let COVID stop your fieldwork: three tips for successful collaborations.
    Nature. 2020 Oct 15. pii: 10.1038/d41586-020-02903.

  275. SCHIERMEIER Q, Else H, Rodriguez Mega E, Padma TV, et al
    What it's really like to do science amid COVID-19.
    Nature. 2020;586:486-487.

    COVID-19 vaccines: time to talk about the uncertainties.
    Nature. 2020;586:475.

  277. GAEBLER C, Nussenzweig MC
    All eyes on a hurdle race for a SARS-CoV-2 vaccine.
    Nature. 2020;586:501-502.

  278. MUTESA L, Ndishimye P, Butera Y, Souopgui J, et al
    A pooled testing strategy for identifying SARS-CoV-2 at low prevalence.
    Nature. 2020 Oct 21. pii: 10.1038/s41586-020-2885.
    PubMed         Abstract available

  279. Nature's second pandemic progress report.
    Nature. 2020;586:473-474.

    Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.
    Nature. 2020 Oct 20. pii: 10.1038/d41586-020-02821.

  281. LEDFORD H
    How obesity could create problems for a COVID vaccine.
    Nature. 2020;586:488-489.

  282. MUNDT AP
    Question hubris in nations' COVID-19 responses.
    Nature. 2020;586:500.

  283. MEGA ER
    Latin America's embrace of an unproven COVID treatment is hindering drug trials.
    Nature. 2020;586:481-482.


  284. MENG X, Liu Y
    Chest Imaging Tests versus RT-PCR Testing for COVID-19 Pneumonia: There Is No Best, Only a Better Fit.
    Radiology. 2020 Oct 20:203792. doi: 10.1148/radiol.2020203792.


  285. SHAMAN J, Galanti M
    Will SARS-CoV-2 become endemic?
    Science. 2020 Oct 14. pii: science.abe5960. doi: 10.1126/science.abe5960.
    PubMed         Abstract available

  286. DE OLIVEIRA G, Chen JM, Stark SC, Berenguer E, et al
    Smoke pollution's impacts in Amazonia.
    Science. 2020;369:634-635.

    The long haul.
    Science. 2020;369:614-617.

    Fast, cheap tests could enable safer reopening.
    Science. 2020;369:608-609.

  289. WADMAN M
    Why infection poses a special risk to pregnant women.
    Science. 2020;369:606-607.

  290. LIPSITCH M, Dean NE
    Understanding COVID-19 vaccine efficacy.
    Science. 2020 Oct 21. pii: science.abe5938. doi: 10.1126/science.abe5938.
    PubMed         Abstract available

  291. COLLINS C
    Productivity in a pandemic.
    Science. 2020;369:603.

  292. GORDON DE, Hiatt J, Bouhaddou M, Rezelj VV, et al
    Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
    Science. 2020 Oct 15. pii: science.abe9403. doi: 10.1126/science.abe9403.
    PubMed         Abstract available

  293. KAISER J
    Found: genes that sway the course of the coronavirus.
    Science. 2020;370:275-276.

  294. ANDRIJEVIC M, Schleussner CF, Gidden MJ, McCollum DL, et al
    COVID-19 recovery funds dwarf clean energy investment needs.
    Science. 2020;370:298-300.

  295. LANGIN K
    Pandemic hits scientist parents hard.
    Science. 2020;369:609-610.

  296. DALY JL, Simonetti B, Klein K, Chen KE, et al
    Neuropilin-1 is a host factor for SARS-CoV-2 infection.
    Science. 2020 Oct 20. pii: science.abd3072. doi: 10.1126/science.abd3072.
    PubMed         Abstract available

  297. BANGARU S, Ozorowski G, Turner HL, Antanasijevic A, et al
    Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
    Science. 2020 Oct 20. pii: science.abe1502. doi: 10.1126/science.abe1502.
    PubMed         Abstract available

  298. BECK DB, Aksentijevich I
    Susceptibility to severe COVID-19.
    Science. 2020;370:404-405.

  299. LEE EC, Wada NI, Grabowski MK, Gurley ES, et al
    The engines of SARS-CoV-2 spread.
    Science. 2020;370:406-407.

  300. CANTUTI-CASTELVETRI L, Ojha R, Pedro LD, Djannatian M, et al
    Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
    Science. 2020 Oct 20. pii: science.abd2985. doi: 10.1126/science.abd2985.
    PubMed         Abstract available

    Travel Med Infect Dis

  301. MALEKI M, Mahmoudi MR, Wraith D, Pho KH, et al
    Time series modelling to forecast the confirmed and recovered cases of COVID-19.
    Travel Med Infect Dis. 2020;37:101742.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.